≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_BREAST_NOS_EXALLC for full statistics.

Carcinoma in situ of breast, other/unspecified

DOID EFO Endpoint Browser

CD2_INSITU_BREAST_NOS

breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D05.7&, D05.9&
  • Hospital discharge: ICD-9 — 2330
  • Cause of death: ICD-10 — D05.7&, D05.9&
  • Cause of death: ICD-9 — 2330

2 out of 7 registries used, show all original rules.

471

4. Check minimum number of events

None

471

5. Include endpoints

None

471

6. Filter based on genotype QC (FinnGen only)

471

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 471 471 -
Unadjusted period prevalence (%) 0.16 0.16 -
Median age at first event (years) 58.47 58.47 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
414
Matched controls
4139
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
+∞
323.0
301
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
82.7
202.0
222
57
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
92.6
141.8
153
26
PJA12
NOMESCO Finland
Sentinel node biopsy
10.8
83.2
185
288
D05.7
ICD-10 Finland
Other carcinoma in situ of breast
+∞
75.3
70
*
HAC20
NOMESCO Finland
Total mastectomy
13.8
75.3
140
148
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
11.7
75.2
154
199
HAB40
NOMESCO Finland
Wedge excision of mammary gland
10.8
70.1
150
207
2330A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Breast
+∞
57.7
54
*
C50.99
ICD-10 Finland
Breast, unspecified
14.0
56.9
102
94
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
22.1
50.7
75
41
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
27.8
46.6
64
27
HA1AA
NOMESCO Finland
X-ray mammography
6.3
44.7
137
301
TQW20
NOMESCO Finland
Tatoe
35.7
43.6
56
18
115
Kela drug reimbursment
Breast cancer
5.7
41.1
138
335
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
6.2
39.4
119
252
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
7.8
38.3
95
152
8503/2-C50.9
ICD-O-3
Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS
+∞
34.9
33
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
5.5
32.0
106
245
C50
ICD-10 Finland
Malignant neoplasm of breast
8.8
28.0
62
81
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
7.1
25.9
66
107
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
23.1
25.2
36
17
D05.0
ICD-10 Finland
Lobular carcinoma in situ
46.1
24.9
30
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
24.6
157
643
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
8.1
24.2
56
78
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
5.7
23.7
72
147
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
5.8
21.8
65
129
ZZR10
NOMESCO Finland
Flap of skin and muscle
19.1
21.2
32
18
N60.9
ICD-10 Finland
Benign mammary dysplasia, unspecified
28.7
20.3
27
10
L02BA01
ATC
tamoxifen; oral
5.6
19.5
59
119
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
6.2
19.4
54
98
Z31.5
ICD-10 Finland
Genetic counselling
6.0
19.3
55
103
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
6.3
18.7
51
90
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
18.7
18.5
28
16
L02BG04
ATC
letrozole; oral
4.1
18.2
76
214
HAD99
NOMESCO Finland
Other plastic operation on breast
36.7
16.8
21
6
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
9.6
16.8
34
38
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
8.4
16.7
37
48
9703
FHL
Breast resection
11.1
16.5
31
30
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
8.7
15.9
34
42
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
20.2
15.7
23
12
H02AB02
ATC
dexamethasone; systemic
3.4
15.7
85
295
N63
ICD-10 Finland
Unspecified lump in breast
3.9
15.3
66
191
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
15.1
177
983
HAB99
NOMESCO Finland
Other partial excision of mammary gland
5.5
14.8
44
87
WX702
NOMESCO Finland
Supraglottic ventilation device
4.6
14.7
53
129
HAE99
NOMESCO Finland
Other reconstruction of breast
13.2
14.6
25
20
D05
ICD-10 Finland
Carcinoma in situ of breast
155.2
14.6
15
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.4
13.9
72
241
A04AA02
ATC
granisetron; systemic, transdermal
4.0
13.8
57
158
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
11.0
13.4
25
24
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
7.5
13.3
31
44
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
23.4
13.0
18
8
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
5.4
13.0
39
78
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
5.2
12.6
39
81
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
8.4
12.5
27
34
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
7.1
12.5
30
45
ZX080
NOMESCO Finland
Image guided radiotherapy
6.7
12.4
31
49
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
8.6
12.2
26
32
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
5.7
11.6
33
62
9702
FHL
Breast exploration and possible tumor removal
7.0
10.9
26
39
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
16.6
10.4
16
10
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
6.9
10.4
25
38
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
20.6
9.9
14
7
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
9.8
123
676
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
5.1
9.7
30
63
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
9.5
36
93
TQB05
NOMESCO Finland
Puncture of skin of trunk
11.0
9.4
17
16
X76
ICPC
Malignant neoplasm breast female
5.0
9.0
28
59
5702
FHL
Local lymph node removal (eg armpit, groin)
12.9
8.9
15
12
HAA10
NOMESCO Finland
Biopsy of mammary gland
9.8
8.9
17
18
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
14.4
8.7
14
10
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
51.1
8.7
10
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
9.3
8.6
17
19
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
4.7
8.5
28
63
PJ5YQ
NOMESCO Finland
NA
+∞
8.4
8
*
HAD40
NOMESCO Finland
Mastopexy
11.1
8.4
15
14
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
14.9
8.2
13
9
HA1AE
SPAT
NA
7.1
8.2
19
28
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
5.6
7.9
22
41
9706
FHL
Ablation mammae, includes axillary exploration
13.4
7.9
13
10
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
45.8
7.7
9
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
5.1
7.7
23
47
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.8
7.6
31
86
HAD20
NOMESCO Finland
Liposuction of breast
81.5
7.4
8
*
A04AD12
ATC
aprepitant; systemic
4.8
7.3
23
50
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
20.4
7.2
10
5
HA1AA
SPAT
NA
5.6
7.0
19
35
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
14.1
6.9
11
8
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
14.1
6.9
11
8
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
9.5
6.8
13
14
C50.59
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology
17.0
6.8
10
6
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
5.1
6.8
20
41
1749X
ICD-9 Finland
Malignant neoplasm of female breast, Breast (female), unspecified
22.9
6.7
9
*
C50.39
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology
12.5
6.6
11
9
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
8.9
6.6
13
15
HA6BA
NOMESCO Finland
Breast tomosynthesis specimen
7.0
6.6
15
22
WX402
NOMESCO Finland
General anaesthesia
2.1
6.5
80
429
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
4.0
6.5
24
62
ZXE00
NOMESCO Finland
One hour or less
1.7
6.4
174
1227
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
11.3
6.3
11
10
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
4.5
6.3
21
49
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
6.4
6.2
15
24
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
6.2
47
202
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
12.8
6.1
10
8
HA3ST
NOMESCO Finland
Removal of lesion of breast with radiological guidance
12.8
6.1
10
8
2393A
ICD-9 Finland
Neoplasm of unspecified nature, Breast
12.8
6.1
10
8
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
6.9
6.1
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
133
409
4.14
38.72
1.4
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
80
181
5.12
34.17
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
121
518
2.80
19.33
1.4
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
35
69
5.40
17.21
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
92
417
2.50
12.68
3.1
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
234
1596
1.93
10.94
3.6
3.3
mmol/l
2.4
2.4
0.34
216
1368
(40768804) Tissue Pathology biopsy report
251
1781
1.88
10.12
2.5
2.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
383
2.28
9.22
4.1
3.5
mmol/l
1.2
1.2
0.47
62
327
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
390
3275
2.11
8.66
9.1
7.1
u/l
73.8
79.2
3.15
362
3043
(40761536) Microorganisms panel - Urine sediment
67
332
2.19
7.37
3.9
4.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
193
1381
1.67
6.68
4.4
3.6
ph
7.4
7.4
0.18
53
253
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
276
2250
1.55
5.03
7.2
5.6
umol/l
9.5
10.3
0.98
257
2118
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
239
1933
1.48
4.24
3.6
3.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
171
1298
1.50
4.13
3.2
3.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
42
3.40
4.07
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
149
1113
1.50
3.84
6.8
6.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
222
1794
1.45
3.82
10.6
9.4
e9/l
0.0
0.0
0.29
183
1469
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
25
4.07
3.71
1.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
143
1838
0.68
3.56
2.0
2.0
pmol/l
99.5
98.1
0.11
67
840
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
417
3876
1.66
3.11
16.0
13.4
ml/min/173m2
77.8
76.7
0.63
369
3145
(3013650) Neutrophils [#/volume] in Blood by Automated count
279
2405
1.39
3.07
10.0
9.0
e9/l
3.5
3.9
4.06
258
2115
(1616796) Gas panel - Central venous blood
19
81
2.40
3.02
3.3
3.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
241
2050
1.36
2.77
5.0
5.0
mmol/l
1.2
1.2
0.08
208
1830
(3024354) Oxygen [Partial pressure] in Venous blood
14
316
0.43
2.67
2.2
2.3
kpa
3.6
4.2
1.58
14
307
(3021447) Carbon dioxide [Partial pressure] in Venous blood
19
376
0.48
2.55
2.4
2.7
kpa
6.2
5.9
0.96
19
366
(3012095) Magnesium [Moles/volume] in Serum or Plasma
88
641
1.46
2.50
2.4
2.8
mmol/l
0.8
0.8
1.03
80
586
(40761535) Cells panel - Urine sediment
18
360
0.48
2.49
2.2
3.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
363
3325
1.40
2.44
19.0
17.7
%
13.6
13.8
1.31
351
3252
(3044640) Blood type and Crossmatch panel - Blood
157
1279
1.34
2.29
2.1
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
331
3001
1.35
2.27
4.0
3.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
383
3555
1.41
2.25
16.3
15.8
%
39.4
38.6
1.23
250
2375
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
129
1.91
2.21
1.4
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
71
509
1.46
2.19
5.0
3.9
ug/l
4.3
10.6
1.80
60
417
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
55
0.00
2.08
0.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
555
0.62
2.05
4.7
6.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
253
2229
1.29
2.03
5.9
5.9
mmol/l
1.2
1.2
0.35
183
1878
(3019150) Specific gravity of Urine by Refractometry
69
923
0.70
1.96
3.7
4.7
kg/l
1.0
1.0
—
7
129
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
10
39
2.60
1.93
1.2
1.2
u/ml
0.1
2.1
—
5
11
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
112
890
1.34
1.90
2.8
2.8
mmol/l
2.5
2.5
0.29
106
782
(40767503) Oxygen content in Capillary blood by calculation
17
86
2.01
1.87
2.8
2.3
%
16.6
15.8
0.32
12
43
(3020682) Albumin/Creatinine [Ratio] in Urine
106
1316
0.75
1.86
3.9
3.8
mg/mmol
10.4
6.0
0.37
51
740
(40761511) CBC panel - Blood by Automated count
436
4181
1.58
1.84
14.7
13.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
47
2.37
1.79
1.0
1.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
20
341
0.57
1.71
3.5
5.0
mmol/l
1.2
1.3
0.64
20
328
(42870588) Differential panel, method unspecified - Blood
161
1364
1.27
1.69
4.2
5.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
16
83
1.96
1.66
3.0
3.7
mmol/l
2.3
3.4
—
10
60
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
77
1.98
1.61
2.3
3.1
e9/l
4.3
4.4
0.09
15
77
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
85
1.91
1.57
2.5
2.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
42
0.00
1.53
0.0
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
304
0.58
1.51
4.0
6.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
103
1247
0.78
1.47
2.8
3.0
mg/l
859.0
261.8
0.32
50
700
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
80
1.90
1.46
2.9
3.4
%
59.5
60.0
0.04
15
80
(3009508) Creatinine [Moles/volume] in Urine
107
1280
0.79
1.37
3.0
3.0
mmol/l
5.5
6.2
1.49
81
1063
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
49
360
1.40
1.37
2.1
3.6
u/ml
22.0
68.3
2.32
44
346
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
354
0.63
1.35
3.3
2.6
ml/min/173m2
64.2
63.3
—
8
140
(21494434) Karyotype in Bone marrow
0
40
0.00
1.33
0.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
86
1052
0.78
1.32
1.5
1.5
nmol/l
19.4
22.2
1.08
68
870
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
371
3887
0.79
1.31
5.1
5.9
mmol/mol
39.2
39.8
0.71
310
3560
(3027273) Bicarbonate [Moles/volume] in Venous blood
11
204
0.53
1.29
2.5
2.5
mmol/l
26.0
25.6
0.19
11
199
(3022313) Gas panel - Capillary blood
8
158
0.50
1.27
3.1
3.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
437
1.35
1.25
2.8
2.2
umol/l
5.7
7.1
0.56
43
381
(3021901) Oxygen saturation in Capillary blood
13
70
1.88
1.25
2.6
2.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
11
198
0.54
1.18
4.0
2.0
%
1.0
1.1
0.40
11
198
(3023323) Follitropin [Units/volume] in Serum or Plasma
21
134
1.59
1.16
1.4
1.3
iu/l
38.8
36.7
0.11
21
114
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
153
0.51
1.16
1.6
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
85
1024
0.79
1.15
2.2
2.2
mg/l
2.6
3.2
1.75
66
856
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
125
0.47
1.06
2.3
2.0
ug/l
897.2
186.6
—
6
113
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
310
0.66
1.05
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
108
922
1.22
1.03
1.5
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
68
829
0.79
1.02
2.0
1.7
nmol/l
1197.5
1229.8
0.09
41
602
(3019832) Treponema pallidum Ab [Presence] in Serum
7
132
0.52
1.00
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
9
161
0.55
0.99
4.4
4.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
155
1734
0.84
0.99
2.5
2.6
ug/l
110.4
100.2
0.40
131
1565
(3011648) Oxygen content in Venous blood
0
29
0.00
0.98
0.0
1.7
—
10.3
—
0
29
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.96
0.97
1.4
1.7
—
—
—
0
0
(4024509)
9
50
1.82
0.97
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
111
958
1.21
0.95
1.4
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
6
27
2.24
0.93
3.2
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
346
0.71
0.91
1.1
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
213
1953
1.17
0.90
2.3
2.3
nmol/l
81.8
80.7
0.25
184
1716
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
29
2.08
0.89
3.2
5.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
49
389
1.29
0.88
2.0
1.9
g/l
0.2
0.2
0.97
42
370
(44813793)
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
187
1.41
0.87
1.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
117
1325
0.84
0.85
2.0
2.0
u/l
138.0
145.7
0.11
106
1246
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
562
0.78
0.84
5.1
4.5
%
35.0
34.0
0.26
27
352
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
30
395
0.74
0.82
1.5
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
14
89
1.59
0.82
2.5
2.8
kpa
8.5
7.8
0.77
14
83
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.81
1.4
1.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
26
0.00
0.78
0.0
2.0
—
9.0
—
0
21
(3008037) Lactate [Moles/volume] in Venous blood
5
99
0.50
0.78
3.4
2.5
mmol/l
2.1
1.6
—
5
99
(3014051) Protein [Presence] in Urine by Test strip
17
115
1.50
0.78
1.6
2.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
59
488
1.24
0.78
3.2
3.8
mmol/l
1.0
1.0
0.00
52
439
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
111
978
1.18
0.76
2.1
2.1
—
—
—
0
0
(1002224) Polysomnography panel
8
134
0.59
0.74
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
120
1068
1.17
0.73
3.7
4.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
109
1.48
0.72
1.7
2.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.4
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.71
1.4
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
27
1.86
0.68
2.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
250
1.30
0.67
1.9
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
93
0.53
0.67
3.4
2.6
mmol/l
8.6
7.6
—
5
93
(3022217) INR in Platelet poor plasma by Coagulation assay
61
516
1.21
0.66
22.5
22.7
inr
1.4
1.2
—
6
72
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
810
0.84
0.65
3.4
3.9
ng/l
281.1
224.9
0.08
53
640
(3019550) Sodium [Moles/volume] in Serum or Plasma
435
4265
1.26
0.64
15.8
16.2
mmol/l
139.9
139.8
0.20
413
4146
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
98
869
1.16
0.63
4.1
4.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
44
362
1.24
0.63
2.3
2.8
g/l
68.8
67.0
0.72
38
326
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
4.2
—
212.1
—
0
21
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
52
1.55
0.59
3.6
1.8
pg
33.4
31.0
—
8
52
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
20.2
—
0
22
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
32.6
—
0
22
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.9
—
50.9
—
0
22
(3022806) Fractional oxyhemoglobin in Capillary blood
8
53
1.52
0.58
1.8
2.0
%
88.4
90.1
—
8
53
(1761482) Bacteria [#/volume] in Urine by Culture
7
115
0.60
0.58
4.3
5.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
75
853
0.86
0.58
2.4
2.6
e6/l
6.7
7.5
0.11
64
764
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
12
172
0.69
0.57
1.9
2.1
g/l
1.6
1.6
—
7
152
(3000330) Specific gravity of Urine by Test strip
29
230
1.28
0.57
2.4
4.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
72
631
1.17
0.55
2.1
2.9
e6/l
2.4
3.5
0.77
37
315
(3051611) Lipemic interference index of Serum or Plasma
6
38
1.59
0.54
5.3
2.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
435
4275
1.23
0.54
16.0
16.3
mmol/l
3.9
3.9
0.09
410
4145
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
66
1.53
0.53
1.3
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
329
3174
1.12
0.52
3.9
4.3
mm/h
13.6
13.5
0.06
284
2899
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
302
0.78
0.51
1.2
1.2
iu/ml
92.5
171.0
—
6
125
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
75
1.48
0.51
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
92
1.42
0.51
1.1
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
179
0.72
0.51
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
38
452
0.83
0.50
4.0
3.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
32
262
1.24
0.50
1.3
1.4
—
33.9
—
0
13
(3048689) Calprotectin [Mass/mass] in Stool
43
505
0.84
0.49
1.9
2.0
ug/g
77.9
123.3
1.35
31
384
(4010399)
26
322
0.80
0.49
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
399
4073
0.87
0.49
4.6
4.9
mmol/l
5.8
5.9
0.40
315
3674
(3025130) Human papilloma virus identified in Specimen
7
45
1.56
0.49
1.0
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
1006
0.88
0.48
2.9
4.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
408
4157
0.86
0.48
5.2
5.3
mmol/l
2.9
2.8
1.36
332
3778
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
23
182
1.28
0.47
3.4
2.6
u/ml
241.8
1000.8
0.47
18
156
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
301
1.21
0.47
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
254
0.78
0.47
2.2
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
110
1006
1.12
0.46
3.1
3.4
%
94.9
94.1
0.09
105
974
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
49
1.43
0.46
1.3
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
165
1.29
0.45
1.1
1.3
—
1.0
—
0
12
(3007853) Bacteria identified in Skin by Aerobe culture
49
424
1.17
0.45
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
121
1.33
0.44
3.8
2.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
436
4296
1.20
0.44
18.3
16.8
umol/l
69.5
70.5
0.53
436
4296
(3003396) Base excess in Arterial blood by calculation
39
456
0.84
0.44
4.7
6.1
mmol/l
2.0
1.7
0.33
30
370
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
128
0.70
0.44
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
299
2886
1.10
0.43
4.1
4.8
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
6
91
0.65
0.42
6.8
3.6
u/ml
81.5
2793.6
—
6
86
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
206
0.77
0.42
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
32
1.57
0.42
1.0
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
198
1877
1.09
0.42
4.3
4.0
g/l
36.3
35.4
1.85
179
1736
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
15
0.00
0.41
0.0
3.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.2
—
31.3
—
0
11
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
23.4
—
1920.7
—
0
16
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
16.8
—
842.3
—
0
16
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
3.0
—
106036.0
—
0
10
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
205
0.77
0.41
7.8
7.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.4
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
138
0.72
0.41
1.4
1.8
mg/l
2.5
2.0
—
10
105
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.4
—
133.5
—
0
17
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
10.1
—
0
17
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
17
0.00
0.40
0.0
1.6
—
768.4
—
0
5
(3019198) Lymphocytes [#/volume] in Blood
197
2071
0.92
0.40
4.7
5.5
e9/l
1.7
1.9
1.66
171
1809
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
438
4322
1.19
0.40
12.5
10.7
u/l
24.8
23.2
0.41
410
4143
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
97
1.35
0.40
2.6
2.9
mmol/l
23.9
25.9
1.63
13
85
(3026493) Urate [Moles/volume] in Serum or Plasma
92
1003
0.90
0.39
2.2
2.5
umol/l
316.2
7085.3
4.97
72
843
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
128
1192
1.10
0.39
1.6
1.6
mmol/l
1.3
1.3
0.24
81
988
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
19
0.00
0.39
0.0
1.1
—
5.7
—
0
19
(3013115) Eosinophils [#/volume] in Blood
202
2118
0.92
0.38
4.7
5.8
e9/l
0.2
0.2
0.46
175
1847
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
5
36
1.39
0.38
1.2
1.3
u/l
—
50.5
—
0
12
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
352
3433
1.10
0.38
4.6
4.4
pmol/l
15.2
15.0
0.84
290
3100
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
136
1273
1.10
0.38
3.3
2.7
u/l
27.8
32.9
0.96
131
1214
(3001604) Monocytes [#/volume] in Blood
193
2026
0.92
0.38
4.6
5.5
e9/l
0.6
0.6
0.00
169
1740
(4094501)
8
113
0.70
0.37
1.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
135
1439
0.91
0.37
2.7
3.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
81
1.37
0.36
1.8
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
76
0.65
0.36
1.4
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
77
0.65
0.36
2.0
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
199
1.22
0.35
1.5
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
396
1.15
0.35
2.2
2.2
u/l
29.4
35.9
0.98
37
321
(3024731) MCV [Entitic volume]
447
4424
1.20
0.34
22.5
21.2
fl
91.4
91.2
0.22
431
4348
(3019060) Gas panel - Arterial blood
23
275
0.83
0.34
4.9
4.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
72
788
0.90
0.34
1.3
1.3
u/ml
23.2
12.4
0.33
25
285
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
53
474
1.13
0.33
1.7
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
447
4425
1.20
0.33
22.6
21.3
e12/l
4.4
4.4
0.27
427
4290
(3007461) Platelets [#/volume] in Blood
447
4425
1.20
0.33
22.6
21.3
e9/l
255.1
260.1
1.09
431
4303
(3035941) MCH [Entitic mass]
447
4425
1.20
0.33
22.4
21.2
pg
30.2
30.2
0.03
431
4349
(3000963) Hemoglobin [Mass/volume] in Blood
447
4425
1.20
0.33
22.6
21.4
g/l
130.8
131.3
0.39
431
4349
(3010813) Leukocytes [#/volume] in Blood
447
4425
1.20
0.33
22.6
21.3
e9/l
6.2
6.5
3.95
427
4287
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
72
657
1.11
0.33
1.8
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
380
3869
0.91
0.33
3.9
4.1
mmol/l
1.2
1.3
0.61
304
3478
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
46
1.31
0.33
2.0
1.5
u/ml
4.3
86.7
—
6
46
(4306422)
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
305
0.84
0.32
2.8
3.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
83
1.33
0.32
1.4
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
195
2035
0.93
0.32
4.6
5.5
e9/l
0.0
0.0
0.97
170
1744
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
208
0.81
0.32
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
72
784
0.90
0.31
2.4
2.8
mosm/kgh2o
482.5
496.7
0.21
59
670
(3028300) Cannabinoids [Presence] in Urine
7
52
1.35
0.31
2.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
52
1.35
0.31
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
52
1.35
0.31
2.0
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
52
1.35
0.31
2.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
52
1.35
0.31
2.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
229
0.82
0.31
1.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
99
0.70
0.31
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
53
1.33
0.31
1.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
54
1.30
0.30
1.1
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
54
1.30
0.30
1.1
1.4
—
—
—
0
0
(4034850)
15
120
1.26
0.30
5.1
8.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
271
0.84
0.30
1.7
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
137
1446
0.93
0.30
3.2
3.8
e6/l
49.1
103.6
1.46
91
1005
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
55
1.28
0.30
1.1
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
55
1.28
0.30
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
55
1.28
0.30
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
16
195
0.81
0.29
1.1
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
109
0.73
0.29
1.1
1.2
—
658.6
—
0
7
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
110
0.72
0.29
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
216
0.83
0.29
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
103
1.27
0.28
4.3
2.4
u/ml
0.3
0.4
—
8
65
(3004616) Nuclear Ab [Presence] in Serum
8
63
1.27
0.28
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
161
0.80
0.27
1.0
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
401
4064
0.91
0.27
4.5
4.7
mmol/l
4.9
4.9
0.63
327
3716
(3013826) Glucose [Moles/volume] in Serum or Plasma
232
2395
0.94
0.27
3.8
4.2
mmol/l
6.4
6.6
0.86
223
2239
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
67
1.20
0.26
1.1
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
5
73
0.68
0.26
1.4
1.2
nmol/l
0.5
0.7
—
5
68
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
398
4033
0.92
0.26
4.5
4.6
mmol/l
1.6
1.6
0.74
323
3663
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
142
1.20
0.25
1.6
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
28
318
0.87
0.25
4.3
2.8
e9/l
77.0
73.7
0.17
22
238
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
87
926
0.93
0.24
1.6
1.7
pmol/l
464.2
15027781.1
0.80
56
732
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
213
2199
0.94
0.24
2.8
2.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
84
0.71
0.24
1.2
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
85
0.70
0.24
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
85
0.70
0.24
1.2
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
56
515
1.10
0.24
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
175
1685
1.06
0.23
10.9
8.3
inr
1.2
1.2
0.05
76
468
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
477
1.10
0.23
1.7
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
58
627
0.91
0.23
2.3
2.1
umol/l
12.3
12.3
0.02
49
569
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
16
134
1.20
0.23
2.2
2.2
g/l
0.0
0.0
0.00
16
124
(3007164) IgA [Mass/volume] in Serum or Plasma
74
791
0.92
0.23
1.7
1.6
g/l
2.0
2.3
0.85
35
433
(3035637) Corticotropin [Mass/volume] in Plasma
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
5.4
4.9
mg/l
12.3
13.3
—
5
36
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
41
1.22
0.22
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
16
135
1.19
0.21
2.2
2.2
g/l
0.0
0.0
0.00
16
125
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
188
0.85
0.21
1.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
76
809
0.93
0.21
1.2
1.3
iu/ml
55.8
37.1
0.22
18
265
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
4.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4198724)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
1.8
—
0
10
(3034426) Prothrombin time (PT)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.4
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
134
0.82
0.21
1.6
1.6
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
13
0.00
0.21
0.0
2.2
—
3.1
—
0
5
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
16
187
0.85
0.20
1.0
1.1
—
134.0
—
0
5
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
14
0.00
0.20
0.0
1.6
—
29.4
—
0
7
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
2.7
—
0
5
(40757373) Influenza virus identified in Isolate
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
256
2500
1.05
0.20
2.9
2.9
u/l
45.1
45.0
0.01
222
2287
(3005322) IgE [Units/volume] in Serum or Plasma
28
250
1.13
0.20
1.2
1.2
u/ml
117.5
137.9
0.21
23
234
(3040151) Glucose [Moles/volume] in Capillary blood
6
49
1.23
0.20
1.2
6.1
mmol/l
7.7
7.5
—
6
40
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
49
1.23
0.20
1.3
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
49
1.23
0.20
1.5
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.5
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
16
137
1.17
0.19
2.2
2.2
g/l
0.0
0.0
0.50
16
127
(3026008) Bacteria identified in Urine by Culture
152
1572
0.95
0.18
3.0
3.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
176
1.14
0.17
2.0
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
115
1104
1.06
0.17
3.8
4.7
estimate
0.0
0.0
0.00
48
364
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
67
0.74
0.17
1.2
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
67
0.74
0.17
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
390
3940
0.94
0.17
5.4
5.4
mu/l
1.8
2.2
0.68
328
3572
(36660697) Celiac disease serology panel - Serum
30
329
0.91
0.16
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
73
692
1.06
0.16
2.1
2.7
e6/l
1.1
1.2
0.14
38
375
(3037522) Nuclear Ab [Titer] in Serum
61
575
1.07
0.16
1.2
1.3
titre
506.7
521.2
0.03
18
135
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
15
130
1.16
0.16
1.1
1.3
—
2.2
—
0
15
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
140
0.85
0.15
2.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
35
323
1.09
0.15
2.9
3.8
%
1.3
0.5
—
10
62
(3025159) Blasts/100 leukocytes in Blood
35
323
1.09
0.15
3.3
4.1
%
0.0
1.3
—
10
67
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
315
0.92
0.14
1.2
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
406
4027
1.06
0.14
14.9
14.1
mg/l
18.6
21.5
1.28
318
3157
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
96
0.83
0.14
1.9
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
98
0.81
0.14
1.4
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
63
661
0.95
0.13
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
114
1104
1.04
0.12
2.7
3.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
158
0.88
0.12
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
51
537
0.94
0.12
2.1
2.2
%
22.3
20.9
0.21
41
448
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
240
0.91
0.11
1.1
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
26
240
1.09
0.11
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
154
1574
0.97
0.10
3.9
4.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
18
197
0.91
0.10
1.4
2.5
e6/l
0.2
0.2
0.12
18
191
(3032773) Endomysium IgG Ab [Titer] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
128
1311
0.97
0.10
1.8
2.2
u/l
50.4
57.4
2.00
107
1188
(3004588) Protein electrophoresis panel - Serum or Plasma
35
330
1.07
0.10
2.3
2.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
5
46
1.09
0.09
1.0
1.2
g/l
30.4
32.1
—
5
41
(3042936) Bacteria identified in Isolate by Culture
60
577
1.05
0.09
1.9
1.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
188
1849
1.03
0.09
4.7
5.7
%
0.7
0.7
0.51
178
1687
(3041354) Potassium [Moles/volume] in Venous blood
5
60
0.83
0.08
1.6
2.1
mmol/l
4.0
4.0
—
5
60
(3035285) Chloride [Moles/volume] in Venous blood
5
60
0.83
0.08
1.6
2.1
mmol/l
103.8
106.1
—
5
60
(3035350) Ketones [Presence] in Urine by Test strip
208
2051
1.03
0.08
3.5
4.2
estimate
0.0
0.0
0.00
48
367
(3008898) HLA-B27 [Presence]
12
133
0.90
0.07
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
36
343
1.05
0.07
1.8
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
195
1924
1.02
0.07
4.9
5.9
%
8.8
8.4
0.57
184
1766
(3002030) Lymphocytes/100 leukocytes in Blood
198
1958
1.02
0.05
4.8
5.8
%
27.6
28.5
0.47
187
1785
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
942
1.02
0.05
1.5
1.6
mg/l
1.5
1.1
0.26
74
735
(3017181) Myelocytes/100 leukocytes in Blood
37
357
1.04
0.05
3.2
3.9
%
1.5
0.9
0.37
13
88
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
157
1587
0.98
0.04
3.5
3.6
ng/l
29.1
50.9
0.47
117
1126
(3009261) Glucose [Presence] in Urine by Test strip
208
2096
0.99
0.03
3.6
4.3
estimate
0.0
0.0
0.80
47
362
(3004789) Transferrin [Mass/volume] in Serum or Plasma
56
572
0.98
0.03
2.1
2.2
g/l
2.2
2.4
2.77
45
524
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
622
0.98
0.03
1.4
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
30
310
0.97
0.03
1.6
1.4
%
1.2
1.4
0.93
24
269
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
10
92
1.09
0.03
1.4
2.2
%
143.7
195.2
—
10
87
(3021440) Promyelocytes/100 leukocytes in Blood
35
340
1.03
0.03
3.4
4.0
%
0.2
0.1
0.35
13
81
(40760888) Immunoglobulin light chains.free panel - Serum
11
102
1.08
0.03
7.2
4.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
127
1283
0.99
0.03
2.5
2.8
ng/l
1015.8
1110.4
0.18
104
1084
(3009343) pH of Capillary blood
21
219
0.96
0.03
2.8
3.3
ph
7.4
7.4
0.60
11
37
(3000494) Fungus identified in Specimen by Culture
51
500
1.02
0.02
1.3
1.3
—
—
—
0
0
(3013512) EKG study
133
1318
1.01
0.02
3.7
3.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
148
0.94
0.02
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
148
0.94
0.02
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
369
0.97
0.02
1.2
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
103
1.07
0.02
1.1
1.3
—
13.4
—
0
7
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
117
0.94
0.01
2.3
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
101
1019
0.99
0.01
4.4
3.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
93
938
0.99
0.01
1.2
1.3
u/ml
0.6
1.6
1.76
22
238
(3002582) Erythrocytes [#/volume] in Urine
122
1212
1.01
0.01
2.7
3.2
e6/l
20.1
59.4
1.46
85
919
(3036481) Cortisol [Moles/volume] in Serum or Plasma
37
377
0.98
0.01
1.8
1.9
nmol/l
370.7
374.4
0.04
32
347
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
114
1.05
0.00
1.8
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
146
0.96
0.00
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
113
1124
1.01
0.00
2.7
3.1
e6/l
0.5
0.4
0.16
79
841
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
145
0.96
0.00
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
104
0.96
0.00
1.7
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
235
1.02
0.00
1.4
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
103
0.97
0.00
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
167
1.02
0.00
1.6
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
26
263
0.99
0.00
2.1
2.9
pmol/l
4.6
4.5
0.19
18
226
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
13
132
0.98
0.00
1.5
1.6
—
100.0
—
0
6
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
407
1.01
0.00
2.2
2.9
ng/l
63.8
76.4
0.72
29
357
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
208
1.01
0.00
2.8
3.2
mmol/l
1.5
2.3
0.62
14
162
(3049717) Cytology report of Urine Cyto stain
12
121
0.99
0.00
1.6
2.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
193
1932
1.00
0.00
4.7
5.5
%
56.9
56.8
0.04
182
1772
(3006504) Eosinophils/100 leukocytes in Blood
192
1916
1.00
0.00
4.7
5.6
%
2.7
2.8
0.51
178
1749
(3021601) Nitrite [Presence] in Urine by Test strip
208
2085
1.00
0.00
4.7
5.8
estimate
0.0
0.0
0.00
47
358
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
103.2
—
0
5
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
7.5
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
27.3
—
0
7
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
1.7
—
136.7
—
0
6
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
99
0.91
0.00
1.2
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
17.6
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
49
1.02
0.00
2.2
2.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
49
1.02
0.00
1.4
1.5
mosm/kgh2o
271.0
274.5
—
5
35
(3042631) Mycobacterium sp identified in Specimen
5
52
0.96
0.00
2.0
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
29.8
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
71
0.99
0.00
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
82
0.98
0.00
2.0
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
67
0.89
0.00
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
64
0.94
0.00
1.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
79
0.88
0.00
1.3
1.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.6
—
0
9
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
59
0.85
0.00
1.6
2.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
7.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
69
1.01
0.00
1.4
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
15.4
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.7
—
0
6
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.6
—
3.5
—
0
9
(3002523) Influenza virus A Ag [Presence] in Specimen
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
8
0.00
0.00
0.0
2.4
—
0.8
—
0
8
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_BREAST_NOS – Carcinoma in situ of breast, other/unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).